Tissue and cell culture (in vitro) studies reported in the 1997 issues of the British Journal of Anaesthesia, Anesthesia and Analgesia, and Anesthesiology were compared with groups of clinical studies selected at random from the same issues. Comparisons were of some basic aspects of study design and reporting that might lead to bias. The aspects examined were sample size, randomization and reporting of exclusions and withdrawals. Two groups of 53 articles were compared: sample size was smaller in in vitro than in clinical studies (median 6 vs 19); randomization was reported in five in vitro studies and in 37 clinical studies; and failures were reported in two in vitro studies and in 43 clinical studies. This hinders interpretation of reported tissue and cell culture studies. Where possible, tissue and cell culture studies should be conducted, reported and assessed for publication to standards equivalent to those for clinical studies. 1999; 82: 295-8 
Many articles published in medical journals are misleading because of methodological weaknesses, 1 and the conduct of some clinical studies has been criticized. 2 Less attention has been paid to the application of good methodological practice in published laboratory studies, although there are published guides (see Singer and Upton 3 and Garner, Barge and Ussary 4 ). Several anaesthesia journals publish reports of both clinical studies and laboratory experiments. We were interested to compare the two types of studies in terms of basic aspects of study design and reporting that might lead to bias. 5 We compared clinical studies with studies of tissue and cell (in vitro) preparations, assuming this to be a greater contrast than with whole animal experiments. We examined three essential features of the reporting of a study: (1) sample size; (2) evidence of randomization; and (3) reporting of reasons for exclusion and withdrawal of subjects or of in vitro preparations from the study.
Methods
We performed a preliminary survey of the 1996 issues of the British Journal of Anaesthesia to see how many in vitro studies were published and to obtain an idea of which © British Journal of Anaesthesia features to note. After this, we surveyed the 12 1997 issues † . We included all articles reporting findings of experiments on isolated in vitro tissue from the 'laboratory investigations' section of the journal. They were compared with the same number of clinical studies from the 'clinical investigations' section. The 'short communications' section was not used. Clinical studies were selected randomly in a matched fashion each month. Thus, for example, three in vitro study articles were published in the February 1997 issue and so three clinical articles were selected randomly from that issue. Randomization was by blind selection of numbered pieces of paper corresponding to the number of clinical studies that month. There were always more clinical studies than in vitro studies in an issue. Clinical studies were excluded if they were not explicitly in vivo work on humans. We carried out a further survey of the 1997 issues of two other anaesthetic journals. We used the same methods when surveying Anesthesia and Analgesia. For Anesthesiology, there was a larger number of in vitro studies reported in † The full list of articles used for this study is available from Dr N. W. Goodman. Please use E-mail if possible (Nev.W.Goodman@ bris.ac.uk); otherwise send a stamped addressed envelope.
each issue, and so we selected at random two in vitro study articles per month and again compared this sample with a randomly selected comparator group of clinical studies chosen as before.
The articles were reviewed for the following information. (1) Number of subjects or preparations. (2) Randomization. This should be reported in the methods section. We looked simply for the words random, randomly or randomization. We made no attempt to assess if the method of randomization was valid. (3) Reporting of exclusions and withdrawals. In clinical studies, we looked for either a description of the type of patient entered into the study or a description of those who were excluded. Writing, for example, ''30 fit ASA I patients undergoing day case laparoscopy'' was classified as adequate description of exclusion as it implies that unhealthy patients were excluded. For the in vitro studies, we judged a simple description of the technique as inadequate unless it was made clear that all the in vitro preparations were included in the study.
Withdrawals should be reported in the results section. We looked for mention of the number of subjects or preparations failing to complete the study (yes/no) and a description of why they were withdrawn (yes/no). We considered statements such as ''All the patients/preparations completed the study'', or ''There were no withdrawals/ failures'', as adequate reporting of withdrawals. If there was no such statement, and even if all subjects might have completed the study, we classified the reporting of withdrawal as inadequate. We felt that the information should be easily available from a brief scan of the article and should not require a detailed search through the whole article looking for consistency of numbers to determine if there were withdrawals. On some occasions, when clinical studies were of intraoperative haemodynamic variables, for example, it was clear from the results that the same number completed the study as were recruited and these were classified as suitable reporting of withdrawals. We allowed the same for in vitro studies as long as the number of in vitro preparations going forward to the experimental procedure was clearly documented, and provided the numbers reported in the results clearly agreed.
Results
Thirteen clinical articles were compared with 13 in vitro articles from the 1997 British Journal of Anaesthesia. Sample sizes were smaller in in vitro studies, randomization was mentioned less commonly, and exclusions and withdrawals were not mentioned (Tables 1, 2) .
We identified 16 in vitro articles from Anesthesia and Analgesia and selected 24 from Anesthesiology. Equivalent numbers of clinical articles were selected for comparison. The details from each article are not shown, but are summarized (with a summary of the British Journal of Anaesthesia findings) in Table 3 . Overall, samples sizes were smaller in in vitro studies, and reporting of random-296 ization and exclusions was less common. Reasons for withdrawal appeared more commonly in reports of clinical studies.
Discussion
Straightforward comparison of clinical and in vitro studies is obviously limited because of the different ways in which clinical and in vitro studies are conducted. There is no single model of research that fits both types of studies; there is no single model that fits all clinical or all in vitro studies. But the risk of bias is present in all research, and we have examined some basic aspects of research method intended to reduce the risk, for example, of selecting particular patients or preparations for one arm of a study, of making a measurement at a favourable time, of rejecting a finding because it does not 'fit in' with preconceived ideas, or of reaching premature conclusions.
There were at least two possible biases in our own study. First, we were expecting the result that we found, and we looked at the American journals after we knew the British findings. Second, for convenience, we matched numbers of clinical and in vitro studies within journal issues. We do not believe that these biases had any important effect on the clear differences we saw in the reporting of our selected studies: reports of in vitro studies were based on fewer observations, reported randomization uncommonly (only five times in 53 articles) and mentioned failures explicitly even less commonly.
There is nothing inherently wrong with studies, whether clinical or laboratory, conducted on small samples. Clinical investigators are becoming familiar with the idea of calculating the power of a study, which relates to the smallest number of patients needed to show that there is a difference between treatments. 6 If a difference is expected to be large, fewer patients are needed. Fewer patients are also needed if the variability of the measure under consideration is small, and lower variability may be more likely for in vitro than for clinical samples. Our impression was that the size of samples was an important consideration for clinical but not for in vitro investigators. There seemed to be an arbitrary acceptance that a sample of five or six was enough, without explanation of why the sample size was chosen. While the numbers studied in each group were almost always clearly stated in the methods section of the clinical studies, finding the same information in the in vitro studies often required detailed searching of text and tables.
The risk with a small sample is of reaching a premature and incorrect conclusion when the vagaries of chance combine with a bias. Randomization and blinding are important ways of preventing bias (and we selected our surveyed articles randomly). Randomization was generally not reported in the in vitro studies. The highest proportion of reported randomization in our sample was from Anesthesia and Analgesia (four of 16). We did not look formally for statements about blinding, but it was obvious during our survey that statements about collection and analysis of data being done by different investigators were less common in in vitro articles. Thus, unlike in most clinical studies, laboratory investigators probably know what is happening while each experiment is going on and are less likely to remain unbiased. This is a worry for two reasons: first, it is an assumption of inferential statistical comparisons that 297 there is no bias; second, for all sorts of reasons, investigators tend to find what they expect to find. 7 If all goes well and all preparations behave in the same way, this is less of a problem. But we find it worrying that so many in vitro studies used small samples while so few reported any withdrawals or failures (only two of 53). We know anecdotally of studies in which investigators have reported only the experiments that work. A series of six experiments, all of which worked, must be regarded differently from a series of, say, 70 experiments, for which a report was compiled after the sixth successful experiment. How, in the longer series, did the investigators decide the experiment had worked? There is a risk of rejecting a finding because it is awkward or inconsistent. To quote Richard Feynman, 8 ''The first principle is that you must not fool yourself-and you are the easiest person to fool''. Without an explicit statement of failures, and an explanation of how the experiments failed, readers cannot interpret the findings correctly. Another issue is that someone repeating the study or method needs to know how many failures to expect: the report of the cloned sheep, Dolly, was explicit in stating that she was the only survivor of 277 attempts. 9 We are not suggesting that the in vitro studies themselves are of poor quality, rather that the reporting of such studies should make the same acknowledgement of the likelihood of bias as clinical studies by reporting randomization, blinding, and withdrawals and failures. Reporting of failures need not be lengthy and detailed, just a note to the effect that, for example, a reagent or cell preparation was unreliable. This need not imply any fault of the experimenters; many experiments are intricate and difficult, and manufacturers' kits and reagents do not always work in the way that they should. Experimenters should have information about failure: good laboratory practice demands that ''all data generated during the conduct of a study should be recorded directly, promptly, accurately, and legibly by the individual entering the data''. 3 There are relevant statements in section II C of the recent draft ethical guidelines of the American Statistical Association: ''5. Account for all data considered in a study and explain the sample(s) actually used. 6. Report the sources and assessed adequacy of the data. 7. Report the data cleaning and screening procedures used...''. 10 We agree that for some laboratory experiments, randomization and blinding are impossible or inappropriate. Randomization and blinding are not possible for some 298 clinical studies, particularly in surgery or in studies in which patient preferences are over-riding. But randomization and blinding are possible sometimes in laboratory studies. Randomization was used in five of our surveyed in vitro studies and, if randomization were impossible, guides to practice would not include the advice that ''the methods for the control of bias (including the randomization procedure...) should be stated''. 4 We looked at only three anaesthesia journals. This is because we are anaesthetists, and we chose these three particular journals because they regularly publish both types of research. We have no reason to believe that reporting in any other clinical specialty or scientific discipline is any better or worse. We should like investigators in all studies, whether human, animal or in vitro, to give reasons for sample size, to use randomization and blinding wherever possible, and to report exclusions and withdrawals. This can only improve the robustness and general applicability of the data published.
